Evidence map›Paper›PMID 35693072›Full record

ArticleAmerican journal of cancer research2022

The potential and limitation of targeted chromosomal breakpoint sequencing for the

Ming-Szu Hung, Yu-Ching Lin, Fen-Fen Chen, Yuan-Yuan Jiang, Yu-Hung Fang, Ming-Shian Lu, Chin-Kuo Lin, Tsung-Ming Yang, Jrhau Lung, Chih-Cheng Chen and 2 more

Open access · greenAbstract read
In one paragraph

Article in American journal of cancer research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Detection ofFrontiers in cell and developmental biology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Ming-Szu HungDepartment of Pulmonary and Critical Care Medicine, Chang Gung Memorial Hospital, Chiayi Branch Taiwan.
Yu-Ching LinDepartment of Pulmonary and Critical Care Medicine, Chang Gung Memorial Hospital, Chiayi Branch Taiwan.
Fen-Fen ChenDepartment of Pathology, Chang Gung Memorial Hospital, Chiayi Branch Taiwan.
Yuan-Yuan JiangDepartment of Pulmonary and Critical Care Medicine, Chang Gung Memorial Hospital, Chiayi Branch Taiwan.
Yu-Hung FangDepartment of Pulmonary and Critical Care Medicine, Chang Gung Memorial Hospital, Chiayi Branch Taiwan.
Ming-Shian LuDepartment of Surgery, Division of Thoracic and Cardiovascular Surgery, Chang Gung Memorial Hospital, Chiayi Branch Taiwan.
Chin-Kuo LinDepartment of Medicine, College of Medicine, Chang Gung University Taoyuan, Taiwan.
Tsung-Ming YangDepartment of Medicine, College of Medicine, Chang Gung University Taoyuan, Taiwan.
Jrhau LungDepartment of Medical Research and Development, Chang Gung Memorial Hospital, Chiayi Branch Taiwan.
Chih-Cheng ChenDepartment of Medicine, College of Medicine, Chang Gung University Taoyuan, Taiwan.
Kuan-Der LeeDepartment of Hematology and Oncology, Taipei Medical University Hospital Taipei 110, Taiwan.
Ying-Huang TsaiDepartment of Respiratory Care, College of Medicine, Chang Gung University Taoyuan, Taiwan.
Chiayi Chang Gung Memorial Hospital · TWChang Gung University · TWChang Gung University of Science and Technology · TWTaipei Medical University Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

FISHIHCLung cancerROS1 fusion geneRT-qPCRtargeted chromosomal breakpoint sequencing

Identifiers

PMID35693072
PMCPMC9185620
OpenAlexW4285740464

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.